Stephen Thomas | Director, Upstate Global Health Institute
New York Upstate Medical University

Stephen Thomas, Director, Upstate Global Health Institute, New York Upstate Medical University

Dr. Stephen J. Thomas is an Infectious Diseases physician-scientist from SUNY Upstate Medical University in Syracuse, NY, USA. He is a Professor of Medicine and Professor of Microbiology & Immunology. Dr. Thomas currently directs the Upstate Global Health Institute and is the Frank E. Young, MD '56 and Leanne Young Endowed Chair of Microbiology & Immunology. He earned his Medical Degree from Albany Medical College and completed his Internal Medicine residency and Infectious Diseases fellowship at the Walter Reed Army Medical Center and the National Capital Consortium. Prior to joining Upstate, Dr. Thomas was a U.S. Army Medical Corps Officer serving at the Walter Reed Army Institute of Research and completed his career as the institute's Deputy Commander for Operations. He specializes in the study of infectious diseases and the development of medical countermeasures. Dr. Thomas has supported and led development and characterization studies of vaccines, drugs, and biologics targeting dengue, Japanese encephalitis, Yellow fever, influenza, rabies, chikungunya, opioid use disorder, Zika, Ebola, and MERS-CoV. During the COVID-19 pandemic he was the global coordinating principal investigator for the Pfizer / BioNTech COVID vaccine efficacy trial. He serves on numerous advisory boards and committees for the US government, international and non-governmental organizations, and industry. He is also a contributor to Forbes magazine and entrepreneur, co-founding several small businesses.

Appearances:



Main Congress Day 1 - 22nd April @ 11:40

Working Group 3: Stronger Together – Value Through Strategic Collaborations - Room 209AB

Session led by: fhi-clinical

Main Congress Day 1 - 22nd April @ 12:25

Keynote panel: The emergence and re-emergence of dengue and its unprecedented worldwide spread

  • Effect of climate change on spread
  • Data on circulating serotypes
  • Introduction of new vaccine in high-risk areas
  • Strengthening surveillance systems in affected countries
  • View on vaccine recommendations
  • Global epidemiology and what increases in Americas have meant to US
last published: 22/Apr/25 22:05 GMT

back to speakers